We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
290 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SUGAMMADEX-AFT sugammadex (as sodium) 500 mg/5 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SUGAMMADEX-AFT sugammadex (as sodium) 200 mg/2 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TIGECYCLINE-AFT tigecycline 50 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GANIRELIX-AFT ganirelix (as acetate) 250 microgram/0.5 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Vevye cyclosporin 1 mg/mL eye drops bottle.
-
Prescription medicine registrationActive ingredients: ganirelix.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Kiwisoothe® Chewable Tablets.
-
Prescription medicine registrationActive ingredients: ciclosporin.
-
Australian public assessment report (AusPar)Pyrazinamide-AFT is indicated in adult patients of more than 12 years of age with active drug-sensitive tuberculosis caused by Mycobacterium tuberculosis. Pyrazinamide-AFT is an anti-tuberculosis agent used in combination with other anti- tuberculosis agents and is commonly used in the first 2 months of treatment.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AFT Pharmaceuticals Pty Ltd - Lubricant, eye.